8th Biennial Australasian Schizophrenia Conference 2004

Session Details

Poster Session

Wednesday, 22 September 2004 12:00 -13:00

Ann Street Lobby

Toughin it Out. Survival Skills for Dealing with Suicidal Thoughts
  • Simon L Bridge
    • Microarray Analysis of Altered Gene Expression in the Mouse Brain After Treatment with Lithium Chloride or Sodium Valproate
  • Dr Albert F Chetcuti, Neuroscience Institute of Schizophrenia and Allied Disorders
    • An Australian Observational Study of Olanzapine Tablet and Wafer Formulations for the Treatment of Inpatients with Schizophrenia
  • Dr R D'Souza, Box Hill Hospital, Box Hill, VIC
    • Transient Low Prenatal Vitamin D Leads to Permanent Down Regulation of Nerve Growth Factor
  • Catherine A Jones, Queensland Centre for Mental Health Research / Griffith University
    • Use of Acceleromtery to Assess Physical Activity and Energy Expenditure in Men Prescribed Clozapine
  • Jenny-Kay Sharpe, The Park - Centre for Mental Health
    • Behavioural and Brain Measures of Sound Lateralization in Schizophrenia
  • Natasha L Matthews, University of Newcastle
    • Selective Estrogen Receptor Modulators (SERMs) – A New Treatment for Schizophrenia?
  • Jayashri Kulkarni, Alfred Psychiatry Research Centre/ Monash University
    • Behavioural Outcomes of Prenatal Vitamin D Deficiency in Rats
  • Dr T H Burne, Griffith University
    • Comorbid Anorexia Nervosa and Psychosis: Two Case Studies
  • Anna M Rybak, Queensland Centre for Mental Health Research
    • Undetected Childhood Psychotic Symptoms: Case Studies
  • Mrs Maria C Sutherland, QCMHR - Queensland Centre for Mental Health Research
    • Autoimmunity in Schizophrenia
  • Amanda L Jones, The University of Queensland
    • Computerised Outcome Instruments for Clinical and Research Use
  • A/Prof Tim Tim Lambert, University of Melbourne
    • A Systematic Review of Pharmacoepidemiolocal Studies in Schizophrenia
  • Lakshika D Tennakoon, Orygen Research Centre
    • The Receptor for Vitamin D and the Enzyme Responsible for its Synthesis are Widely Distributed in Human Brain
  • Dr Darryl W Eyles, QCMHR, The University of Queensland
    • Prenatal Vitamin D Deficiency Causes Behavioural Changes in Adult Offspring - A Role for Dopamine?
  • Dr Darryl W Eyles, QCMHR, The University of Queensland
    • A Systematic Review of the Prevalence of Schizophrenia: The Impact of Migrant Status
  • Sukanta Saha, Queensland Centre for Mental Health Research
    • Mitosis and Apoptosis are Temporally Regulated by Ablation of the Vitamin D Receptor
  • Miss Pauline Ko, QCMHR, The University of Queensland
    • Valuing Schizophrenia Health States
  • Mr Steven Crowley, Janssen-Cilag Pty Ltd and Program Evaluation Unit, Melbourne University.
    • Catatonia in Schizophrenia: Symptom Patterns and Treatment Responses
  • Dr Joseph W Y Lee, Graylands Hospital
    • Episode II: Prevention of Relapse Following Early Psychosis
  • Belinda V Newman, ORYGEN Youth Health
    • Transient Prenatal and Early Life Hypovitaminosis D Induce Permanent Alterations in Brain Morphology, Cell Density and Gene Expression Consistent with Alterations Observed in Schizophrenia
  • Miss Pauline Ko, QCMHR, The University of Queensland
    • FMRI BOLD Cerebellar Activation of First-episode Schizophrenia Patients
  • Ulrich Schall, Centre for Mental Health Studies, University of Newcastle
    • The Effectiveness of Switch to Aripiprazole Stratified by Prior Antipsychotic
  • Lee Anne Griffiths, Bristol-Myers Squibb
    • The Effect of Atypical Antipsychotic Drugs on New Onset Diabetes in Schizophrenia: A Review and Meta-Analysis
  • Elizabeth Hale, Bristol-Myers Squibb
    • Comparative One Year Incidence/Worsening of Metabolic Syndrome Among Patients Treated with Olanzapine vs Aripiprazole
  • Dr Greg Cook, Bristol-Myers Squibb
    • Differential Gene Expression in the Amygdala and Superior Temporal Gyrus in Schizophrenia
  • Paul A Tooney, NISAD / University of Newcastle
    • Neuroprotective Effects of Low-dose Lithium, in Individuals at Ultra High-Risk of Developing Psychosis: A Case Series
  • Margaret L Dell'Olio, Pace Clinic, Orygen Research Centre – Dept. Of Psychiatry, University of Melbourne.
    • A Cross-cultural Comparison of Depot Prescribing Among Outpatient Populations
  • Tim J Lambert, University of Melbourne
    • The Influence of Menstrual Cycle Fluctuations in Sex Hormones on Hemispheric Asymmetry in Women with Schizophrenia
  • Mr Anthony R de Castella, Alfred Psychiatry Research Centre, Monash University Department of Psychological Medicine
    • Normalization of Endocrine Parameters in Patients Commencing Treatment with Aripiprazole
  • Natalie Krapivensky, International Institute of Psychopharmacology
    • An MRI Study of Corpus Callosum Morphology in First-episode Psychosis
  • Ms Catherine Croft, Melbourne Neuropsychiatry Centre, Royal Melbourne Hospital, Melbourne
    • Australian Study of Twins with Psychosis- Progress to Date
  • Dr Dominique Hannah, Queensland Centre for Mental Health Research
    • Familiality of Symptoms and Symptom Dimensions in a Sample of Indian Families
  • Associate Professor B J Mowry, Queensland Centre for Mental Health Research and Queensland Institute of Medical Research
    • Sample Collection and Processing for Molecular Genetic Studies of Schizophrenia
  • Ms Heather J Smith, Queensland Centre for Mental Health Research and Queensland Institute of Medical Research
    • Molecular Genetics of Schizophrenia Study
  • Ms Deborah Nertney, Queensland Centre for Mental Health Research
    • The Process of Recovery from First Episode Psychotic Illness: An Ethnographic Study in Java, Indonesia
  • Dr Subandi, The University of Adelaide
    • Expression Profiling Schizophrenia in Fibroblasts
  • Nick Matigian, Queensland Institute of Medical Research, Bancroft Centre, Queensland Centre for Schizophrenia Research, Wolston Park Hospital